CoChat

EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions

Open access
Hashemi, Mehrdad, Arani, Hamid Zaferani, Orouei, Sima, Fallah, Shayan, Ghorbani, Amin, Khaledabadi, Maryam, Kakavand, Amirabbas, Tavakolpournegari, Alireza, Saebfar, Hamidreza, Heidari, Hajar, Salimimoghadam, Shokooh, Entezari, Maliheh, Taheriazam, Afshin, Hushmandi, Kiavash · 2022 · Biomedicine & Pharmacotherapy
Cited by 166

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

One of the malignant tumors in women that has involved both developed and developing countries is breast cancer. Similar to other types of tumors, breast cancer cells demonstrate high metastatic nature. Besides, breast tumor cells have ability of developing drug resistance. EMT is the related mechanism to cancer metastasis and focus of current manuscript is highlighting function of EMT in breast tumor malignancy and drug resistance. Breast tumor cells increase their migration by EMT induction During EMT, N-cadherin and vimentin levels increase, and E-cadherin levels decrease to mediate EMT-induced breast tumor invasion. Different kinds of anti-cancer agents such as tamoxifen, cisplatin and paclitaxel that EMT induction mediates chemoresistance feature of breast tumor cells. Furthermore, EMT induction correlates with radio-resistance in breast tumor. Clinical aspect is reversing EMT in preventing chemotherapy or radiotherapy failure in breast cancer patients and improving their survival time. The anti-tumor agents that suppress EMT can be used for decreasing breast cancer invasion and increasing chemosensitivity of tumor cells. Furthermore, lncRNAs, miRNAs and other factors can modulate EMT in breast tumor progression that are discussed here.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2022.113774

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Metadata

Authors
Hashemi, M., Arani, H. Z., Orouei, S., Fallah, S., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., Salimimoghadam, S., Entezari, M., Taheriazam, A., & Hushmandi, K.
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2022-11
Volume
155
Pages
113774
ISSN
0753-3322 (ISSN-L)
OpenAlex
W4300687572
Cited by
166
References
8
FWCI
12.33
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. https://app.cochat.ai/papers/10.1016/j.biopha.2022.113774
The paper
Hashemi, M., Arani, H. Z., Orouei, S., Fallah, S., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., Salimimoghadam, S., Entezari, M., Taheriazam, A., & Hushmandi, K. (2022). EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2022.113774

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.